title: Lenalidomide induces remission and mixed quantitative chimerism fluctuations in refractory and relapsed myeloid malignancy with del (5).
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Dumas
authors.forename: Arnaud
authors.initials: A
authors.lastname: Pigneux
authors.forename: Reza
authors.initials: R
authors.lastname: Tabrizi
authors.forename: Noel
authors.initials: N
authors.lastname: Milpied
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D046528:Chimerism; D002872:Chromosome Deletion; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics; D012074:Remission Induction / Q000379:methods; D016879:Salvage Therapy / Q000379:methods; D017384:Sequence Deletion; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide